beclobrate has been researched along with Hyperlipoproteinemia Type II in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avogaro, P; Bittolo Bon, G; Bufalino, L; Cazzolato, G; Soldan, S | 1 |
Ljachnicky, N; Uglesić, A | 1 |
2 trial(s) available for beclobrate and Hyperlipoproteinemia Type II
Article | Year |
---|---|
A cross-over controlled study on beclobrate versus bezafibrate in the treatment of type IIb hyperlipoproteinaemia.
Topics: Adult; Aged; Benzhydryl Compounds; Bezafibrate; Delayed-Action Preparations; Female; Hemodynamics; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Randomized Controlled Trials as Topic | 1989 |
[Long-term therapy of type II and type IV hyperlipoproteinemia using beclobrate].
Topics: Aged; Benzhydryl Compounds; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Male; Middle Aged; Triglycerides | 1988 |